| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ultrasonography, Prenatal | 85 | 2021 | 152 | 14.430 |
Why?
|
| Ultrasonography | 65 | 2024 | 712 | 5.460 |
Why?
|
| Fetus | 19 | 2021 | 232 | 3.640 |
Why?
|
| Pregnancy | 150 | 2021 | 3018 | 3.590 |
Why?
|
| Ovarian Neoplasms | 22 | 2023 | 765 | 3.160 |
Why?
|
| Ultrasonography, Doppler | 12 | 2021 | 85 | 2.490 |
Why?
|
| Pregnancy Trimester, First | 16 | 2021 | 63 | 2.230 |
Why?
|
| Obstetrics | 11 | 2021 | 123 | 2.230 |
Why?
|
| Pregnancy Complications | 16 | 2017 | 345 | 1.950 |
Why?
|
| Placenta | 10 | 2014 | 179 | 1.790 |
Why?
|
| Ovary | 9 | 2023 | 262 | 1.530 |
Why?
|
| Fetal Diseases | 22 | 2017 | 82 | 1.500 |
Why?
|
| Female | 183 | 2023 | 46222 | 1.470 |
Why?
|
| Gestational Age | 38 | 2017 | 329 | 1.460 |
Why?
|
| Prenatal Diagnosis | 15 | 2017 | 110 | 1.450 |
Why?
|
| Disinfection | 3 | 2024 | 15 | 1.440 |
Why?
|
| Fetal Heart | 5 | 2015 | 13 | 1.260 |
Why?
|
| Adnexal Diseases | 3 | 2023 | 16 | 1.250 |
Why?
|
| Equipment Contamination | 4 | 2024 | 23 | 1.230 |
Why?
|
| Cervix Uteri | 7 | 2015 | 70 | 1.230 |
Why?
|
| Gynecology | 5 | 2020 | 129 | 1.160 |
Why?
|
| Contrast Media | 11 | 2016 | 1092 | 1.160 |
Why?
|
| Ultrasonics | 6 | 2020 | 39 | 1.120 |
Why?
|
| Humans | 193 | 2024 | 89367 | 1.110 |
Why?
|
| Internationality | 6 | 2020 | 69 | 1.110 |
Why?
|
| Acoustics | 7 | 2021 | 51 | 1.100 |
Why?
|
| Prenatal Exposure Delayed Effects | 6 | 2010 | 158 | 1.080 |
Why?
|
| Imaging, Three-Dimensional | 6 | 2018 | 599 | 1.080 |
Why?
|
| Point-of-Care Systems | 4 | 2024 | 147 | 1.070 |
Why?
|
| Chickens | 16 | 2021 | 212 | 0.960 |
Why?
|
| Safety | 8 | 2021 | 149 | 0.960 |
Why?
|
| Practice Guidelines as Topic | 12 | 2024 | 1048 | 0.900 |
Why?
|
| Disease Models, Animal | 16 | 2021 | 2367 | 0.880 |
Why?
|
| Patient Safety | 4 | 2021 | 217 | 0.870 |
Why?
|
| Transducers | 2 | 2024 | 42 | 0.800 |
Why?
|
| Image Enhancement | 4 | 2015 | 567 | 0.790 |
Why?
|
| Interleukin-16 | 4 | 2018 | 7 | 0.770 |
Why?
|
| Thorax | 1 | 2021 | 77 | 0.750 |
Why?
|
| Unnecessary Procedures | 3 | 2011 | 51 | 0.740 |
Why?
|
| Pneumonia, Viral | 3 | 2020 | 319 | 0.740 |
Why?
|
| Coronavirus Infections | 3 | 2020 | 304 | 0.740 |
Why?
|
| Cross Infection | 2 | 2020 | 147 | 0.740 |
Why?
|
| Infection Control | 3 | 2024 | 120 | 0.730 |
Why?
|
| Infectious Disease Transmission, Professional-to-Patient | 1 | 2020 | 4 | 0.720 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 30 | 0.710 |
Why?
|
| Personal Protective Equipment | 1 | 2020 | 33 | 0.710 |
Why?
|
| Equipment Safety | 3 | 2020 | 33 | 0.710 |
Why?
|
| Ultrasonography, Doppler, Color | 6 | 2021 | 37 | 0.700 |
Why?
|
| Pregnancy Trimester, Second | 7 | 2021 | 69 | 0.700 |
Why?
|
| Pleural Effusion | 2 | 2018 | 47 | 0.650 |
Why?
|
| Turner Syndrome | 1 | 2018 | 27 | 0.630 |
Why?
|
| Pregnancy Outcome | 14 | 2015 | 254 | 0.630 |
Why?
|
| Placental Circulation | 3 | 2008 | 11 | 0.620 |
Why?
|
| Cheek | 4 | 2005 | 22 | 0.610 |
Why?
|
| Pandemics | 3 | 2020 | 773 | 0.600 |
Why?
|
| Algorithms | 3 | 2017 | 1877 | 0.600 |
Why?
|
| Ideal Body Weight | 1 | 2017 | 2 | 0.590 |
Why?
|
| Hereditary Breast and Ovarian Cancer Syndrome | 1 | 2017 | 10 | 0.590 |
Why?
|
| Fetal Weight | 2 | 2009 | 15 | 0.580 |
Why?
|
| Lung | 4 | 2021 | 1262 | 0.580 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2017 | 16 | 0.570 |
Why?
|
| Radiation Injuries | 2 | 2008 | 162 | 0.560 |
Why?
|
| Hot Temperature | 3 | 2008 | 207 | 0.540 |
Why?
|
| Albumins | 3 | 2011 | 129 | 0.540 |
Why?
|
| Quality Assurance, Health Care | 1 | 2017 | 225 | 0.520 |
Why?
|
| Teratoma | 3 | 2014 | 51 | 0.520 |
Why?
|
| Fetal Growth Retardation | 6 | 2021 | 67 | 0.520 |
Why?
|
| Adenocarcinoma | 1 | 2023 | 1195 | 0.510 |
Why?
|
| Adult | 76 | 2018 | 26625 | 0.500 |
Why?
|
| Societies, Medical | 11 | 2021 | 578 | 0.490 |
Why?
|
| Placenta Previa | 1 | 2014 | 3 | 0.490 |
Why?
|
| Sacrococcygeal Region | 1 | 2014 | 9 | 0.490 |
Why?
|
| Obstetric Labor, Premature | 3 | 2015 | 58 | 0.480 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2014 | 85 | 0.470 |
Why?
|
| Consumer Product Safety | 2 | 2010 | 11 | 0.460 |
Why?
|
| Uterus | 5 | 2007 | 222 | 0.450 |
Why?
|
| Consensus | 2 | 2020 | 357 | 0.440 |
Why?
|
| Risk Assessment | 8 | 2013 | 2304 | 0.440 |
Why?
|
| Obesity, Morbid | 2 | 2015 | 232 | 0.430 |
Why?
|
| Sensitivity and Specificity | 12 | 2023 | 2014 | 0.430 |
Why?
|
| Thermosensing | 1 | 2012 | 4 | 0.420 |
Why?
|
| Infant, Newborn | 21 | 2021 | 2486 | 0.410 |
Why?
|
| Fetal Macrosomia | 4 | 2005 | 10 | 0.410 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2012 | 39 | 0.410 |
Why?
|
| Amniotic Fluid | 7 | 2015 | 30 | 0.410 |
Why?
|
| Thermography | 3 | 2007 | 14 | 0.400 |
Why?
|
| Umbilical Arteries | 5 | 1994 | 17 | 0.400 |
Why?
|
| Hearing | 1 | 2012 | 57 | 0.400 |
Why?
|
| Body Mass Index | 1 | 2015 | 773 | 0.400 |
Why?
|
| Genital Diseases, Female | 4 | 2020 | 24 | 0.400 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2017 | 3448 | 0.390 |
Why?
|
| Diagnosis, Differential | 9 | 2022 | 1597 | 0.370 |
Why?
|
| Cervical Ripening | 1 | 2010 | 4 | 0.370 |
Why?
|
| Labor Onset | 1 | 2010 | 2 | 0.370 |
Why?
|
| Fluorocarbons | 1 | 2011 | 72 | 0.370 |
Why?
|
| Prospective Studies | 16 | 2021 | 4293 | 0.370 |
Why?
|
| Obesity | 1 | 2017 | 971 | 0.360 |
Why?
|
| Anthropometry | 2 | 2009 | 75 | 0.360 |
Why?
|
| Endometrium | 2 | 2006 | 50 | 0.360 |
Why?
|
| Professional Competence | 2 | 2012 | 69 | 0.350 |
Why?
|
| Body Temperature | 5 | 2012 | 125 | 0.340 |
Why?
|
| Nuchal Cord | 2 | 2006 | 2 | 0.340 |
Why?
|
| Patient Rights | 1 | 2009 | 16 | 0.330 |
Why?
|
| Nuchal Translucency Measurement | 1 | 2008 | 2 | 0.330 |
Why?
|
| Animals | 25 | 2024 | 27380 | 0.330 |
Why?
|
| Maternal Exposure | 1 | 2008 | 58 | 0.310 |
Why?
|
| Neovascularization, Pathologic | 2 | 2012 | 364 | 0.310 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2017 | 2662 | 0.300 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2012 | 538 | 0.290 |
Why?
|
| Noise | 1 | 2007 | 26 | 0.280 |
Why?
|
| Congenital Abnormalities | 3 | 2012 | 64 | 0.280 |
Why?
|
| Students, Medical | 3 | 2021 | 419 | 0.270 |
Why?
|
| Receptors, Tumor Necrosis Factor | 2 | 2016 | 90 | 0.270 |
Why?
|
| Surveys and Questionnaires | 5 | 2018 | 2630 | 0.270 |
Why?
|
| Kidney Pelvis | 1 | 2006 | 51 | 0.260 |
Why?
|
| Hemolysis | 2 | 2003 | 64 | 0.260 |
Why?
|
| Functional Laterality | 2 | 2008 | 200 | 0.260 |
Why?
|
| Urologic Diseases | 1 | 2006 | 44 | 0.260 |
Why?
|
| Young Adult | 6 | 2018 | 6316 | 0.260 |
Why?
|
| Precancerous Conditions | 2 | 2009 | 200 | 0.260 |
Why?
|
| Radiometry | 1 | 2005 | 56 | 0.260 |
Why?
|
| Tamoxifen | 1 | 2006 | 168 | 0.250 |
Why?
|
| Erythrocytes | 2 | 2003 | 254 | 0.250 |
Why?
|
| Amnion | 3 | 2015 | 15 | 0.250 |
Why?
|
| Delivery, Obstetric | 1 | 2005 | 118 | 0.240 |
Why?
|
| Umbilical Cord | 4 | 1991 | 40 | 0.240 |
Why?
|
| Sex Factors | 3 | 2015 | 1067 | 0.230 |
Why?
|
| Fetal Membranes, Premature Rupture | 2 | 2015 | 18 | 0.230 |
Why?
|
| Reproducibility of Results | 5 | 2015 | 2759 | 0.220 |
Why?
|
| Cross-Sectional Studies | 5 | 2017 | 1714 | 0.220 |
Why?
|
| Skull | 2 | 2017 | 255 | 0.220 |
Why?
|
| Endometrial Neoplasms | 1 | 2006 | 205 | 0.220 |
Why?
|
| Risk | 2 | 2017 | 657 | 0.220 |
Why?
|
| Diagnostic Imaging | 1 | 2007 | 479 | 0.210 |
Why?
|
| Radiation Dosage | 3 | 2008 | 226 | 0.200 |
Why?
|
| Amniocentesis | 7 | 1993 | 31 | 0.200 |
Why?
|
| Radiation Protection | 1 | 2022 | 26 | 0.200 |
Why?
|
| Oviducts | 1 | 2021 | 6 | 0.200 |
Why?
|
| Mass Screening | 2 | 2020 | 636 | 0.200 |
Why?
|
| Skin Aging | 1 | 2021 | 29 | 0.190 |
Why?
|
| Ultrasonic Therapy | 1 | 2021 | 34 | 0.190 |
Why?
|
| Cosmetic Techniques | 1 | 2021 | 28 | 0.190 |
Why?
|
| Placenta Diseases | 2 | 2008 | 13 | 0.190 |
Why?
|
| Risk Factors | 8 | 2018 | 5497 | 0.190 |
Why?
|
| Organ Size | 2 | 2015 | 371 | 0.190 |
Why?
|
| Intestine, Small | 1 | 2023 | 299 | 0.190 |
Why?
|
| Pregnancy, Multiple | 5 | 2008 | 37 | 0.180 |
Why?
|
| Cesarean Section | 9 | 2014 | 141 | 0.180 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2021 | 56 | 0.180 |
Why?
|
| Gloves, Protective | 1 | 2020 | 3 | 0.180 |
Why?
|
| Eye Protective Devices | 1 | 2020 | 3 | 0.180 |
Why?
|
| Blood Flow Velocity | 5 | 2007 | 200 | 0.180 |
Why?
|
| Ventilation | 1 | 2020 | 8 | 0.180 |
Why?
|
| Respiratory Protective Devices | 1 | 2020 | 3 | 0.180 |
Why?
|
| Curriculum | 3 | 2021 | 568 | 0.180 |
Why?
|
| Diagnostic Techniques, Obstetrical and Gynecological | 1 | 2020 | 2 | 0.180 |
Why?
|
| Hygiene | 1 | 2020 | 10 | 0.180 |
Why?
|
| Hand Hygiene | 1 | 2020 | 10 | 0.180 |
Why?
|
| Containment of Biohazards | 1 | 2020 | 9 | 0.180 |
Why?
|
| Polysaccharides | 1 | 2001 | 90 | 0.180 |
Why?
|
| Heart Rate, Fetal | 4 | 2005 | 17 | 0.180 |
Why?
|
| Physician-Patient Relations | 1 | 2006 | 625 | 0.180 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2021 | 95 | 0.180 |
Why?
|
| Masks | 1 | 2020 | 29 | 0.170 |
Why?
|
| 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 1 | 1999 | 7 | 0.170 |
Why?
|
| Neoplasm Staging | 5 | 2013 | 2018 | 0.170 |
Why?
|
| Calcinosis | 2 | 2008 | 230 | 0.170 |
Why?
|
| Early Diagnosis | 2 | 2018 | 125 | 0.170 |
Why?
|
| Retrospective Studies | 9 | 2023 | 9058 | 0.170 |
Why?
|
| Vasoconstrictor Agents | 1 | 1999 | 56 | 0.170 |
Why?
|
| Triage | 1 | 2020 | 111 | 0.170 |
Why?
|
| Brain | 3 | 2024 | 2285 | 0.170 |
Why?
|
| Pregnancy Complications, Infectious | 3 | 2006 | 117 | 0.170 |
Why?
|
| Immunohistochemistry | 4 | 2016 | 1800 | 0.160 |
Why?
|
| Vasodilator Agents | 1 | 1999 | 146 | 0.160 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2021 | 179 | 0.160 |
Why?
|
| Embryonic and Fetal Development | 3 | 1997 | 72 | 0.160 |
Why?
|
| Abdomen | 3 | 1997 | 122 | 0.160 |
Why?
|
| Vagina | 3 | 2017 | 174 | 0.160 |
Why?
|
| Polycystic Ovary Syndrome | 3 | 2018 | 206 | 0.160 |
Why?
|
| Femur | 2 | 1989 | 112 | 0.160 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2015 | 689 | 0.150 |
Why?
|
| Dose-Response Relationship, Radiation | 2 | 2008 | 188 | 0.150 |
Why?
|
| Fetal Development | 2 | 2015 | 31 | 0.150 |
Why?
|
| Health Personnel | 1 | 2020 | 215 | 0.150 |
Why?
|
| CA-125 Antigen | 1 | 2017 | 22 | 0.150 |
Why?
|
| Parietal Bone | 1 | 1997 | 20 | 0.150 |
Why?
|
| Cranial Sutures | 2 | 2017 | 47 | 0.150 |
Why?
|
| Pilot Projects | 2 | 2017 | 871 | 0.140 |
Why?
|
| Antibodies, Neoplasm | 2 | 2009 | 84 | 0.140 |
Why?
|
| Diabetes, Gestational | 2 | 2009 | 40 | 0.140 |
Why?
|
| Single-Blind Method | 3 | 2007 | 150 | 0.140 |
Why?
|
| Fetal Movement | 3 | 1993 | 4 | 0.140 |
Why?
|
| Meconium | 2 | 1994 | 15 | 0.140 |
Why?
|
| Education, Medical | 1 | 2020 | 243 | 0.140 |
Why?
|
| Betacoronavirus | 1 | 2020 | 261 | 0.140 |
Why?
|
| Premature Birth | 2 | 2015 | 117 | 0.140 |
Why?
|
| Encephalocele | 3 | 1993 | 26 | 0.140 |
Why?
|
| Carcinogenesis | 1 | 2018 | 211 | 0.140 |
Why?
|
| Face | 1 | 2017 | 116 | 0.140 |
Why?
|
| Immunomodulation | 1 | 2016 | 58 | 0.140 |
Why?
|
| Gene Expression | 2 | 2021 | 1310 | 0.140 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2021 | 447 | 0.130 |
Why?
|
| Obstetric Labor Complications | 3 | 2006 | 34 | 0.130 |
Why?
|
| Body Weight | 1 | 1997 | 452 | 0.130 |
Why?
|
| Decision Support Techniques | 1 | 2017 | 167 | 0.130 |
Why?
|
| Temperature | 3 | 2010 | 405 | 0.130 |
Why?
|
| Biophysics | 2 | 2010 | 153 | 0.130 |
Why?
|
| Cervical Length Measurement | 1 | 2015 | 1 | 0.130 |
Why?
|
| Hydrops Fetalis | 5 | 1993 | 16 | 0.130 |
Why?
|
| Male | 17 | 2015 | 42423 | 0.130 |
Why?
|
| Cephalometry | 2 | 1993 | 50 | 0.130 |
Why?
|
| Macrophages | 1 | 2018 | 572 | 0.130 |
Why?
|
| Carcinoma | 2 | 2021 | 443 | 0.130 |
Why?
|
| Indigo Carmine | 1 | 2015 | 3 | 0.130 |
Why?
|
| Microvessels | 1 | 2015 | 69 | 0.120 |
Why?
|
| Coloring Agents | 1 | 2015 | 65 | 0.120 |
Why?
|
| Prolapse | 1 | 2014 | 10 | 0.120 |
Why?
|
| Pregnancy, Ectopic | 3 | 2008 | 36 | 0.120 |
Why?
|
| Ultrasonography, Doppler, Pulsed | 2 | 2012 | 5 | 0.120 |
Why?
|
| Down Syndrome | 2 | 1993 | 55 | 0.120 |
Why?
|
| Pregnancy in Diabetics | 2 | 1991 | 38 | 0.120 |
Why?
|
| Meconium Aspiration Syndrome | 1 | 1994 | 4 | 0.120 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2015 | 201 | 0.120 |
Why?
|
| Integrin alpha5 | 1 | 2014 | 6 | 0.120 |
Why?
|
| Infarction | 1 | 1994 | 27 | 0.120 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2014 | 17 | 0.120 |
Why?
|
| Integrin beta3 | 1 | 2014 | 32 | 0.110 |
Why?
|
| Pregnancy Trimester, Third | 6 | 2015 | 70 | 0.110 |
Why?
|
| Molecular Probes | 1 | 2014 | 35 | 0.110 |
Why?
|
| Skull Neoplasms | 1 | 1993 | 30 | 0.110 |
Why?
|
| Abnormalities, Multiple | 2 | 2014 | 234 | 0.110 |
Why?
|
| Carcinoma, Acinar Cell | 1 | 2013 | 12 | 0.110 |
Why?
|
| Hemangioma | 1 | 1993 | 64 | 0.110 |
Why?
|
| Cohort Studies | 2 | 2015 | 2873 | 0.110 |
Why?
|
| Predictive Value of Tests | 6 | 2005 | 1725 | 0.110 |
Why?
|
| Vibration | 3 | 2005 | 50 | 0.110 |
Why?
|
| Time Factors | 7 | 2011 | 5339 | 0.110 |
Why?
|
| Chromosome Aberrations | 2 | 1992 | 390 | 0.110 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2016 | 595 | 0.110 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2013 | 48 | 0.110 |
Why?
|
| Early Detection of Cancer | 1 | 2017 | 416 | 0.110 |
Why?
|
| Aneuploidy | 2 | 2012 | 57 | 0.110 |
Why?
|
| Spinal Dysraphism | 1 | 1993 | 19 | 0.110 |
Why?
|
| Trisomy | 2 | 1993 | 54 | 0.110 |
Why?
|
| Dietary Supplements | 1 | 2013 | 125 | 0.110 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 1992 | 20 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 9 | 2 | 1993 | 86 | 0.110 |
Why?
|
| United States | 5 | 2017 | 6997 | 0.100 |
Why?
|
| Auditory Threshold | 1 | 2012 | 15 | 0.100 |
Why?
|
| Pressure | 2 | 2012 | 165 | 0.100 |
Why?
|
| Sound Spectrography | 1 | 2012 | 19 | 0.100 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2018 | 1266 | 0.100 |
Why?
|
| Causality | 1 | 2012 | 80 | 0.100 |
Why?
|
| Snoring | 1 | 1991 | 12 | 0.100 |
Why?
|
| Killer Cells, Natural | 1 | 2013 | 275 | 0.100 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 2011 | 14 | 0.100 |
Why?
|
| Cranial Sinuses | 1 | 2011 | 15 | 0.100 |
Why?
|
| Abruptio Placentae | 1 | 1991 | 13 | 0.100 |
Why?
|
| Pregnancy Complications, Hematologic | 1 | 1991 | 15 | 0.100 |
Why?
|
| Urinary Bladder | 3 | 2006 | 246 | 0.100 |
Why?
|
| Papillary Muscles | 1 | 1991 | 17 | 0.100 |
Why?
|
| Sucking Behavior | 1 | 1991 | 5 | 0.100 |
Why?
|
| Plant Extracts | 1 | 2013 | 245 | 0.100 |
Why?
|
| Brain Diseases | 1 | 2013 | 186 | 0.100 |
Why?
|
| Human Experimentation | 1 | 1991 | 39 | 0.100 |
Why?
|
| Fatty Liver | 1 | 1992 | 95 | 0.100 |
Why?
|
| Chordae Tendineae | 1 | 1991 | 23 | 0.100 |
Why?
|
| Microbubbles | 2 | 2016 | 36 | 0.100 |
Why?
|
| Hiccup | 1 | 1991 | 5 | 0.100 |
Why?
|
| Electroconvulsive Therapy | 1 | 1991 | 25 | 0.100 |
Why?
|
| Cleft Lip | 1 | 1991 | 15 | 0.100 |
Why?
|
| Yawning | 1 | 1991 | 1 | 0.100 |
Why?
|
| Lip | 1 | 1991 | 16 | 0.100 |
Why?
|
| Forearm | 1 | 1991 | 31 | 0.100 |
Why?
|
| Hydronephrosis | 2 | 2006 | 32 | 0.090 |
Why?
|
| Heart Septum | 1 | 1991 | 47 | 0.090 |
Why?
|
| Twins | 5 | 1994 | 65 | 0.090 |
Why?
|
| Incidental Findings | 2 | 2021 | 98 | 0.090 |
Why?
|
| Punctures | 1 | 1990 | 30 | 0.090 |
Why?
|
| Cocaine | 1 | 1991 | 76 | 0.090 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 1990 | 27 | 0.090 |
Why?
|
| Uterine Diseases | 1 | 1990 | 19 | 0.090 |
Why?
|
| Biomechanical Phenomena | 2 | 2005 | 476 | 0.090 |
Why?
|
| Muscles | 1 | 1991 | 193 | 0.090 |
Why?
|
| Biomarkers, Tumor | 2 | 2012 | 1552 | 0.090 |
Why?
|
| Sleep Apnea Syndromes | 1 | 1991 | 107 | 0.090 |
Why?
|
| Birth Weight | 2 | 2008 | 148 | 0.090 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2013 | 446 | 0.090 |
Why?
|
| Depressive Disorder | 1 | 1991 | 221 | 0.090 |
Why?
|
| Thrombocytopenia | 1 | 1991 | 187 | 0.090 |
Why?
|
| Hand | 1 | 1991 | 133 | 0.090 |
Why?
|
| Bacterial Infections | 1 | 1991 | 184 | 0.090 |
Why?
|
| Ovarian Follicle | 5 | 2009 | 72 | 0.090 |
Why?
|
| Liver | 2 | 2011 | 1207 | 0.090 |
Why?
|
| Epidermal Growth Factor | 1 | 1990 | 117 | 0.080 |
Why?
|
| Steroids | 1 | 1990 | 174 | 0.080 |
Why?
|
| Lymphangioma | 1 | 1989 | 15 | 0.080 |
Why?
|
| Reference Values | 2 | 2007 | 661 | 0.080 |
Why?
|
| Neoplasms, Experimental | 1 | 2011 | 269 | 0.080 |
Why?
|
| Perfusion | 2 | 2001 | 236 | 0.080 |
Why?
|
| Heart Atria | 1 | 1991 | 281 | 0.080 |
Why?
|
| Umbilical Veins | 1 | 2008 | 46 | 0.080 |
Why?
|
| B-Lymphocytes | 1 | 2013 | 739 | 0.080 |
Why?
|
| Glucose Tolerance Test | 1 | 2009 | 227 | 0.080 |
Why?
|
| Acoustic Stimulation | 5 | 1998 | 127 | 0.080 |
Why?
|
| Dyslexia | 1 | 2008 | 11 | 0.080 |
Why?
|
| Speech Disorders | 1 | 2008 | 19 | 0.080 |
Why?
|
| Trophoblastic Tumor, Placental Site | 1 | 2008 | 1 | 0.080 |
Why?
|
| Embryo Implantation | 1 | 2008 | 26 | 0.080 |
Why?
|
| Dilatation, Pathologic | 2 | 2006 | 55 | 0.070 |
Why?
|
| Methotrexate | 2 | 2003 | 250 | 0.070 |
Why?
|
| Middle Aged | 6 | 2013 | 25989 | 0.070 |
Why?
|
| Cerebral Ventricles | 1 | 1988 | 78 | 0.070 |
Why?
|
| Hematocrit | 3 | 2003 | 68 | 0.070 |
Why?
|
| Hysterosalpingography | 1 | 2007 | 7 | 0.070 |
Why?
|
| Antigens, Neoplasm | 2 | 2009 | 332 | 0.070 |
Why?
|
| Substance-Related Disorders | 1 | 1991 | 415 | 0.070 |
Why?
|
| Time | 1 | 2007 | 76 | 0.070 |
Why?
|
| Hypertension | 4 | 1997 | 745 | 0.070 |
Why?
|
| Burns | 1 | 2009 | 141 | 0.070 |
Why?
|
| Hydrocephalus | 1 | 1988 | 104 | 0.070 |
Why?
|
| Rats | 3 | 2024 | 4041 | 0.070 |
Why?
|
| Pregnancy Complications, Cardiovascular | 3 | 1992 | 109 | 0.070 |
Why?
|
| Ludwig's Angina | 1 | 2006 | 1 | 0.070 |
Why?
|
| Apgar Score | 1 | 2005 | 13 | 0.070 |
Why?
|
| Submandibular Gland Diseases | 1 | 2006 | 9 | 0.070 |
Why?
|
| Body Burden | 1 | 2005 | 9 | 0.070 |
Why?
|
| Head and Neck Neoplasms | 2 | 1993 | 1063 | 0.070 |
Why?
|
| Gallstones | 1 | 2006 | 17 | 0.070 |
Why?
|
| Adolescent | 5 | 2007 | 9267 | 0.070 |
Why?
|
| Models, Animal | 1 | 2007 | 276 | 0.070 |
Why?
|
| Liability, Legal | 1 | 2006 | 32 | 0.060 |
Why?
|
| Dystocia | 1 | 2005 | 2 | 0.060 |
Why?
|
| Karyotyping | 5 | 1993 | 253 | 0.060 |
Why?
|
| Prenatal Care | 1 | 2006 | 77 | 0.060 |
Why?
|
| Withholding Treatment | 1 | 2006 | 117 | 0.060 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2006 | 157 | 0.060 |
Why?
|
| Child, Preschool | 1 | 2012 | 3733 | 0.060 |
Why?
|
| Truth Disclosure | 1 | 2006 | 93 | 0.060 |
Why?
|
| Parity | 1 | 2005 | 96 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2007 | 899 | 0.060 |
Why?
|
| Tachycardia | 1 | 1985 | 37 | 0.060 |
Why?
|
| Fetal Monitoring | 4 | 1992 | 19 | 0.060 |
Why?
|
| Disease Progression | 3 | 2016 | 1489 | 0.060 |
Why?
|
| Fetal Death | 3 | 1993 | 57 | 0.060 |
Why?
|
| Logistic Models | 2 | 2006 | 1213 | 0.060 |
Why?
|
| Chi-Square Distribution | 1 | 2005 | 360 | 0.060 |
Why?
|
| Probability | 1 | 2005 | 353 | 0.060 |
Why?
|
| Attitude of Health Personnel | 1 | 2009 | 649 | 0.060 |
Why?
|
| Erythrocyte Volume | 1 | 2003 | 3 | 0.060 |
Why?
|
| Fetofetal Transfusion | 2 | 1993 | 8 | 0.060 |
Why?
|
| Erythrocyte Count | 1 | 2003 | 22 | 0.060 |
Why?
|
| Blood Viscosity | 1 | 2003 | 16 | 0.060 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 2003 | 20 | 0.060 |
Why?
|
| Abortifacient Agents, Nonsteroidal | 1 | 2003 | 11 | 0.050 |
Why?
|
| Acute Disease | 4 | 1993 | 841 | 0.050 |
Why?
|
| Bariatric Surgery | 1 | 2006 | 195 | 0.050 |
Why?
|
| Regional Blood Flow | 2 | 1995 | 198 | 0.050 |
Why?
|
| Arteries | 2 | 1995 | 180 | 0.050 |
Why?
|
| Equipment Design | 1 | 2003 | 415 | 0.050 |
Why?
|
| Radiation, Nonionizing | 1 | 2022 | 1 | 0.050 |
Why?
|
| Stress, Mechanical | 1 | 2003 | 253 | 0.050 |
Why?
|
| Rabbits | 1 | 2003 | 639 | 0.050 |
Why?
|
| United States Food and Drug Administration | 1 | 2002 | 135 | 0.050 |
Why?
|
| Kidney | 2 | 2006 | 1147 | 0.050 |
Why?
|
| Neoplasm Proteins | 1 | 2005 | 540 | 0.050 |
Why?
|
| Vascular Resistance | 2 | 2007 | 100 | 0.050 |
Why?
|
| PAX2 Transcription Factor | 1 | 2021 | 6 | 0.050 |
Why?
|
| WT1 Proteins | 1 | 2021 | 20 | 0.050 |
Why?
|
| Esthetics | 1 | 2021 | 45 | 0.050 |
Why?
|
| International Cooperation | 1 | 2002 | 125 | 0.050 |
Why?
|
| Guidelines as Topic | 1 | 2002 | 160 | 0.050 |
Why?
|
| In Vitro Techniques | 2 | 2001 | 996 | 0.050 |
Why?
|
| World Health Organization | 1 | 2022 | 106 | 0.050 |
Why?
|
| Species Specificity | 1 | 2003 | 684 | 0.050 |
Why?
|
| Policy | 1 | 2021 | 35 | 0.050 |
Why?
|
| Chromosome Disorders | 2 | 1992 | 115 | 0.050 |
Why?
|
| Vascular Diseases | 1 | 1982 | 118 | 0.050 |
Why?
|
| Biology | 1 | 2021 | 52 | 0.050 |
Why?
|
| Models, Biological | 1 | 2008 | 1765 | 0.050 |
Why?
|
| Ovarian Cysts | 2 | 2007 | 17 | 0.050 |
Why?
|
| Placenta Growth Factor | 1 | 2021 | 72 | 0.050 |
Why?
|
| Prognosis | 4 | 2005 | 3787 | 0.050 |
Why?
|
| Fetal Blood | 1 | 2001 | 93 | 0.050 |
Why?
|
| Decision Making | 1 | 2006 | 667 | 0.040 |
Why?
|
| Abortion, Induced | 3 | 2003 | 136 | 0.040 |
Why?
|
| Thromboxanes | 1 | 1999 | 7 | 0.040 |
Why?
|
| Injections, Intra-Arterial | 1 | 1999 | 33 | 0.040 |
Why?
|
| Nitroglycerin | 1 | 1999 | 23 | 0.040 |
Why?
|
| Wound Healing | 1 | 1982 | 359 | 0.040 |
Why?
|
| Israel | 2 | 2012 | 57 | 0.040 |
Why?
|
| Microspheres | 1 | 1999 | 108 | 0.040 |
Why?
|
| Regression Analysis | 3 | 2001 | 590 | 0.040 |
Why?
|
| Schools, Medical | 1 | 2020 | 134 | 0.040 |
Why?
|
| Ovulation Induction | 2 | 1990 | 34 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2021 | 414 | 0.040 |
Why?
|
| Biophysical Phenomena | 1 | 1998 | 124 | 0.040 |
Why?
|
| Hand Deformities, Congenital | 1 | 1997 | 15 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2003 | 2884 | 0.040 |
Why?
|
| Cranial Fontanelles | 1 | 2017 | 1 | 0.040 |
Why?
|
| Superoxide Dismutase | 1 | 2018 | 177 | 0.040 |
Why?
|
| Mice | 2 | 2013 | 11764 | 0.040 |
Why?
|
| Evaluation Studies as Topic | 2 | 1995 | 270 | 0.040 |
Why?
|
| Body Height | 1 | 1997 | 100 | 0.040 |
Why?
|
| Genitalia, Female | 1 | 1997 | 25 | 0.040 |
Why?
|
| Analgesia, Obstetrical | 1 | 1996 | 21 | 0.040 |
Why?
|
| Bupivacaine | 1 | 1996 | 45 | 0.030 |
Why?
|
| Posture | 1 | 1996 | 124 | 0.030 |
Why?
|
| Labor, Obstetric | 1 | 1996 | 46 | 0.030 |
Why?
|
| Fentanyl | 1 | 1996 | 71 | 0.030 |
Why?
|
| Abortion, Spontaneous | 2 | 1995 | 66 | 0.030 |
Why?
|
| Nerve Block | 1 | 1996 | 50 | 0.030 |
Why?
|
| Ovulation Detection | 2 | 1987 | 6 | 0.030 |
Why?
|
| Anesthetics, Local | 1 | 1996 | 76 | 0.030 |
Why?
|
| Immunoglobulins | 1 | 2016 | 144 | 0.030 |
Why?
|
| Infant | 2 | 2021 | 3161 | 0.030 |
Why?
|
| Magnesium Sulfate | 2 | 1992 | 15 | 0.030 |
Why?
|
| Ureaplasma urealyticum | 1 | 2015 | 1 | 0.030 |
Why?
|
| Ureaplasma Infections | 1 | 2015 | 3 | 0.030 |
Why?
|
| Chorioamnionitis | 1 | 2015 | 21 | 0.030 |
Why?
|
| Diseases in Twins | 2 | 1993 | 65 | 0.030 |
Why?
|
| Cell Movement | 1 | 2018 | 784 | 0.030 |
Why?
|
| Injections | 1 | 2015 | 116 | 0.030 |
Why?
|
| Polyhydramnios | 1 | 1994 | 1 | 0.030 |
Why?
|
| Aged | 3 | 2012 | 19175 | 0.030 |
Why?
|
| Microcephaly | 2 | 1993 | 76 | 0.030 |
Why?
|
| Urinary Retention | 2 | 1993 | 42 | 0.030 |
Why?
|
| Antibodies | 1 | 2016 | 353 | 0.030 |
Why?
|
| Biomarkers | 1 | 2021 | 1767 | 0.030 |
Why?
|
| Infusions, Parenteral | 1 | 1994 | 51 | 0.030 |
Why?
|
| Acidosis | 1 | 1994 | 55 | 0.030 |
Why?
|
| Culdoscopy | 1 | 1993 | 1 | 0.030 |
Why?
|
| Poultry Diseases | 1 | 2013 | 13 | 0.030 |
Why?
|
| Postoperative Complications | 3 | 1991 | 2282 | 0.030 |
Why?
|
| Gingival Hemorrhage | 1 | 1993 | 1 | 0.030 |
Why?
|
| Toothbrushing | 1 | 1993 | 2 | 0.030 |
Why?
|
| HELLP Syndrome | 1 | 1993 | 8 | 0.030 |
Why?
|
| Heart Injuries | 1 | 1993 | 19 | 0.030 |
Why?
|
| Spinal Puncture | 1 | 1993 | 37 | 0.030 |
Why?
|
| Cleft Palate | 1 | 1993 | 26 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2015 | 261 | 0.030 |
Why?
|
| Appendicitis | 2 | 1992 | 64 | 0.030 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 1993 | 14 | 0.030 |
Why?
|
| Lymphocyte Count | 1 | 2013 | 98 | 0.030 |
Why?
|
| Hydatidiform Mole | 1 | 1993 | 6 | 0.030 |
Why?
|
| Twins, Monozygotic | 1 | 1993 | 57 | 0.030 |
Why?
|
| Lung Injury | 1 | 1993 | 53 | 0.030 |
Why?
|
| Ectromelia | 1 | 1993 | 4 | 0.030 |
Why?
|
| Amniotic Band Syndrome | 1 | 1993 | 3 | 0.030 |
Why?
|
| Cardiac Output, High | 1 | 1993 | 3 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1994 | 501 | 0.030 |
Why?
|
| Sacrum | 1 | 1993 | 43 | 0.030 |
Why?
|
| Cystic Adenomatoid Malformation of Lung, Congenital | 1 | 1992 | 3 | 0.030 |
Why?
|
| False Negative Reactions | 1 | 1992 | 63 | 0.030 |
Why?
|
| Chick Embryo | 1 | 2013 | 230 | 0.030 |
Why?
|
| Accidents, Traffic | 1 | 1993 | 98 | 0.030 |
Why?
|
| Exudates and Transudates | 1 | 1992 | 14 | 0.030 |
Why?
|
| Infant, Low Birth Weight | 1 | 1992 | 58 | 0.030 |
Why?
|
| Labor Presentation | 1 | 1992 | 4 | 0.030 |
Why?
|
| False Positive Reactions | 1 | 1992 | 223 | 0.030 |
Why?
|
| Echocardiography, Doppler | 1 | 1993 | 186 | 0.030 |
Why?
|
| Hydrothorax | 1 | 1992 | 1 | 0.030 |
Why?
|
| Tocolysis | 1 | 1992 | 1 | 0.030 |
Why?
|
| Tocolytic Agents | 1 | 1992 | 8 | 0.030 |
Why?
|
| Magnesium | 1 | 1992 | 178 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 1996 | 448 | 0.030 |
Why?
|
| Facial Bones | 1 | 1992 | 37 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2006 | 3012 | 0.030 |
Why?
|
| Cardiotocography | 1 | 1991 | 7 | 0.020 |
Why?
|
| Infant, Premature, Diseases | 1 | 1992 | 77 | 0.020 |
Why?
|
| Urinary Fistula | 1 | 1991 | 7 | 0.020 |
Why?
|
| Blood Group Incompatibility | 1 | 1991 | 20 | 0.020 |
Why?
|
| Anus, Imperforate | 1 | 1991 | 11 | 0.020 |
Why?
|
| Meglumine | 1 | 2011 | 38 | 0.020 |
Why?
|
| Urethral Diseases | 1 | 1991 | 15 | 0.020 |
Why?
|
| Mosaicism | 1 | 1992 | 70 | 0.020 |
Why?
|
| Rectal Fistula | 1 | 1991 | 18 | 0.020 |
Why?
|
| ABO Blood-Group System | 1 | 1991 | 58 | 0.020 |
Why?
|
| Tachycardia, Ventricular | 1 | 1992 | 124 | 0.020 |
Why?
|
| Reflex, Stretch | 1 | 1991 | 5 | 0.020 |
Why?
|
| Fallopian Tube Diseases | 1 | 1991 | 4 | 0.020 |
Why?
|
| Systole | 1 | 1991 | 115 | 0.020 |
Why?
|
| Sound | 1 | 1991 | 25 | 0.020 |
Why?
|
| Urinary Incontinence | 1 | 1993 | 213 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 1992 | 266 | 0.020 |
Why?
|
| Infant, Small for Gestational Age | 1 | 1990 | 29 | 0.020 |
Why?
|
| Embryo Transfer | 1 | 1990 | 30 | 0.020 |
Why?
|
| Organometallic Compounds | 1 | 2011 | 137 | 0.020 |
Why?
|
| Fertilization in Vitro | 1 | 1990 | 57 | 0.020 |
Why?
|
| Contraceptives, Oral | 1 | 1990 | 46 | 0.020 |
Why?
|
| Menstrual Cycle | 1 | 1990 | 54 | 0.020 |
Why?
|
| Coronary Disease | 1 | 1992 | 260 | 0.020 |
Why?
|
| Respiratory Mechanics | 1 | 1991 | 102 | 0.020 |
Why?
|
| Acute Kidney Injury | 1 | 1994 | 312 | 0.020 |
Why?
|
| Neural Tube Defects | 2 | 1988 | 44 | 0.020 |
Why?
|
| Pre-Eclampsia | 1 | 1993 | 254 | 0.020 |
Why?
|
| Congresses as Topic | 1 | 2010 | 113 | 0.020 |
Why?
|
| Hysterectomy | 1 | 1991 | 151 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2009 | 27 | 0.020 |
Why?
|
| Catheterization | 1 | 1990 | 237 | 0.020 |
Why?
|
| Immunoassay | 1 | 2009 | 91 | 0.020 |
Why?
|
| Leydig Cell Tumor | 1 | 1988 | 3 | 0.020 |
Why?
|
| Estradiol | 2 | 1987 | 251 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2009 | 106 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2009 | 104 | 0.020 |
Why?
|
| Luteolytic Agents | 1 | 1988 | 1 | 0.020 |
Why?
|
| Pulmonary Embolism | 1 | 1991 | 228 | 0.020 |
Why?
|
| Pterygium | 1 | 1988 | 1 | 0.020 |
Why?
|
| Recurrence | 1 | 1991 | 1144 | 0.020 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2009 | 112 | 0.020 |
Why?
|
| Hypertrophy | 1 | 1988 | 67 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2009 | 268 | 0.020 |
Why?
|
| Plasma | 2 | 2001 | 51 | 0.020 |
Why?
|
| Androgens | 1 | 1988 | 176 | 0.020 |
Why?
|
| Follow-Up Studies | 3 | 2006 | 3667 | 0.020 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 1988 | 108 | 0.020 |
Why?
|
| Pulsatile Flow | 1 | 2007 | 50 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1993 | 561 | 0.020 |
Why?
|
| Menotropins | 1 | 1986 | 21 | 0.020 |
Why?
|
| Brain Neoplasms | 1 | 1993 | 782 | 0.020 |
Why?
|
| Chorionic Gonadotropin | 1 | 1986 | 72 | 0.020 |
Why?
|
| Myotonic Dystrophy | 1 | 1986 | 7 | 0.020 |
Why?
|
| Hormones | 1 | 1987 | 139 | 0.020 |
Why?
|
| Leg | 2 | 1988 | 140 | 0.020 |
Why?
|
| Tooth Extraction | 1 | 2006 | 10 | 0.020 |
Why?
|
| Sampling Studies | 1 | 2006 | 72 | 0.020 |
Why?
|
| Maternal Age | 1 | 2005 | 45 | 0.020 |
Why?
|
| Cysts | 1 | 1987 | 106 | 0.020 |
Why?
|
| Infant Mortality | 1 | 2005 | 59 | 0.020 |
Why?
|
| Labor, Induced | 1 | 2005 | 30 | 0.020 |
Why?
|
| Appendix | 1 | 1985 | 31 | 0.020 |
Why?
|
| Tracheostomy | 1 | 2006 | 44 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 1998 | 8245 | 0.020 |
Why?
|
| Abscess | 1 | 1985 | 94 | 0.020 |
Why?
|
| Digoxin | 1 | 1985 | 21 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2006 | 1840 | 0.020 |
Why?
|
| Postoperative Period | 1 | 2006 | 302 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2007 | 782 | 0.020 |
Why?
|
| Drainage | 1 | 2006 | 162 | 0.020 |
Why?
|
| Edema | 1 | 1985 | 70 | 0.020 |
Why?
|
| Coma | 1 | 1984 | 47 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2006 | 988 | 0.010 |
Why?
|
| Heating | 1 | 2002 | 14 | 0.010 |
Why?
|
| Syndrome | 2 | 1997 | 449 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2003 | 285 | 0.010 |
Why?
|
| Erythrocyte Indices | 1 | 2001 | 9 | 0.010 |
Why?
|
| Viscosity | 1 | 2001 | 46 | 0.010 |
Why?
|
| Postoperative Care | 1 | 1982 | 231 | 0.010 |
Why?
|
| Blood Proteins | 1 | 2001 | 146 | 0.010 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2005 | 602 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2006 | 788 | 0.010 |
Why?
|
| Foot Deformities, Congenital | 1 | 1997 | 10 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 1997 | 117 | 0.010 |
Why?
|
| Cerebrospinal Fluid Pressure | 1 | 1996 | 6 | 0.010 |
Why?
|
| Anesthesia, Spinal | 1 | 1996 | 15 | 0.010 |
Why?
|
| Injections, Spinal | 1 | 1996 | 45 | 0.010 |
Why?
|
| Anesthesia, Obstetrical | 1 | 1996 | 28 | 0.010 |
Why?
|
| Headache | 1 | 1996 | 72 | 0.010 |
Why?
|
| Pedigree | 1 | 1997 | 970 | 0.010 |
Why?
|
| Linear Models | 1 | 1996 | 421 | 0.010 |
Why?
|
| Foot Deformities | 1 | 1993 | 6 | 0.010 |
Why?
|
| Hepatomegaly | 1 | 1993 | 16 | 0.010 |
Why?
|
| Hemothorax | 1 | 1993 | 15 | 0.010 |
Why?
|
| Urinary Tract | 1 | 1994 | 35 | 0.010 |
Why?
|
| Agenesis of Corpus Callosum | 1 | 1993 | 25 | 0.010 |
Why?
|
| Pericardial Effusion | 1 | 1993 | 20 | 0.010 |
Why?
|
| Platelet Transfusion | 1 | 1993 | 16 | 0.010 |
Why?
|
| Glucose | 1 | 1996 | 630 | 0.010 |
Why?
|
| Twins, Dizygotic | 1 | 1993 | 40 | 0.010 |
Why?
|
| Hernia, Diaphragmatic | 1 | 1993 | 10 | 0.010 |
Why?
|
| Potassium Chloride | 1 | 1993 | 86 | 0.010 |
Why?
|
| Platelet Count | 1 | 1993 | 93 | 0.010 |
Why?
|
| Craniocerebral Trauma | 1 | 1993 | 56 | 0.010 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 1993 | 24 | 0.010 |
Why?
|
| Blood Transfusion | 1 | 1993 | 169 | 0.010 |
Why?
|
| Arm | 1 | 1993 | 97 | 0.010 |
Why?
|
| Ascitic Fluid | 1 | 1992 | 38 | 0.010 |
Why?
|
| Breech Presentation | 1 | 1992 | 12 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 1993 | 160 | 0.010 |
Why?
|
| Coombs Test | 1 | 1991 | 8 | 0.010 |
Why?
|
| Oligohydramnios | 1 | 1991 | 2 | 0.010 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 1991 | 44 | 0.010 |
Why?
|
| Cerebellum | 1 | 1993 | 249 | 0.010 |
Why?
|
| Chorion | 1 | 1991 | 14 | 0.010 |
Why?
|
| Hemorrhage | 1 | 1993 | 280 | 0.010 |
Why?
|
| Hospitals, University | 1 | 1992 | 196 | 0.010 |
Why?
|
| Lung Diseases | 1 | 1993 | 269 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 1993 | 263 | 0.010 |
Why?
|
| Observer Variation | 1 | 1993 | 610 | 0.010 |
Why?
|
| Torsion Abnormality | 1 | 1991 | 17 | 0.010 |
Why?
|
| Heart Diseases | 1 | 1993 | 298 | 0.010 |
Why?
|
| Neck | 1 | 1991 | 104 | 0.010 |
Why?
|
| Chorionic Villi | 1 | 1990 | 11 | 0.010 |
Why?
|
| Urinary Catheterization | 1 | 1991 | 36 | 0.010 |
Why?
|
| Radiography | 1 | 1993 | 809 | 0.010 |
Why?
|
| Infant, Premature | 1 | 1992 | 298 | 0.010 |
Why?
|
| Stress, Physiological | 1 | 1991 | 232 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 1991 | 465 | 0.010 |
Why?
|
| Critical Care | 1 | 1993 | 380 | 0.010 |
Why?
|
| Radiography, Thoracic | 1 | 1991 | 321 | 0.010 |
Why?
|
| Electrocardiography | 1 | 1992 | 496 | 0.010 |
Why?
|
| Hemodynamics | 1 | 1993 | 730 | 0.010 |
Why?
|
| Virilism | 1 | 1988 | 6 | 0.010 |
Why?
|
| Triptorelin Pamoate | 1 | 1988 | 8 | 0.000 |
Why?
|
| Pregnancy, Unwanted | 1 | 1988 | 4 | 0.000 |
Why?
|
| Spina Bifida Occulta | 1 | 1988 | 6 | 0.000 |
Why?
|
| Anencephaly | 1 | 1988 | 7 | 0.000 |
Why?
|
| Incidence | 1 | 1992 | 1596 | 0.000 |
Why?
|
| Chicago | 1 | 1992 | 1427 | 0.000 |
Why?
|
| Follicle Stimulating Hormone | 1 | 1987 | 147 | 0.000 |
Why?
|
| Luteinizing Hormone | 1 | 1987 | 167 | 0.000 |
Why?
|
| Progesterone | 1 | 1987 | 110 | 0.000 |
Why?
|
| Child | 1 | 1997 | 7175 | 0.000 |
Why?
|
| Cecal Diseases | 1 | 1985 | 5 | 0.000 |
Why?
|
| Rupture, Spontaneous | 1 | 1985 | 43 | 0.000 |
Why?
|
| Parenteral Nutrition | 1 | 1984 | 63 | 0.000 |
Why?
|
| Hemophilia B | 1 | 1982 | 4 | 0.000 |
Why?
|
| Fetoscopy | 1 | 1982 | 8 | 0.000 |
Why?
|
| Hemophilia A | 1 | 1982 | 8 | 0.000 |
Why?
|
| Embolism, Air | 1 | 1982 | 23 | 0.000 |
Why?
|
| Brain Injuries | 1 | 1984 | 164 | 0.000 |
Why?
|
| Laparoscopy | 1 | 1985 | 773 | 0.000 |
Why?
|